InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,881.26
(
0.94%
)
Post# of 689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

damnthetorpedoes

Send PM Follow Ignore
Followers 0
Posts 94
Boards Moderated 0
Alias Born 05/10/2012

damnthetorpedoes

Re: gandalf2325 post# 499

Sunday, 09/16/2012 12:47:50 PM

Sunday, September 16, 2012 12:47:50 PM

Post# of 689
The biggest problem I see is that the company is run by scientists. While they may know their science, they don't have a clue about markets and investors. Witness their latest news release. I believe the market has spoken with a collective "who cares" regarding its usefulness. The poster presentation didn't really show anything new regarding Brilacidin, or at least not enough to trigger a PPS increase.

We all know what the company needs to get investor interest but it appears that Nic and company think the science should be enough.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up